Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.